Adverse Event Patterns of Anterior Cruciate Ligament Fixation Devices: A Manufacturer and User Facility Device Experience (MAUDE) Database Analysis (2016–2025)
PM&R · 2026-11 · 18 (S3)
DOI: 10.1002/pmrj.81_70259 ↗Kurz gefasst
Fachartikel in der Zeitschrift PM&R, online erschienen am 10.11.2026. Verfasst von Yazan Al‐Ajlouni und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Main Outcome Measures: Incident TKA after cohort entry Results: Following propensity matching and exclusion of patients with prior TKA outcome codes, arthroplasty occurred in 657 of 24,143 tirzepatide-treated patients (2.7%) and 895 of 24,152 semaglutide-treated patients (3.7%), corresponding to a risk difference of -1.0% (95% confidence interval, -1.3% to -0.7%; P < 0.001), risk ratio of 0.734 (95% confidence interval, 0.665-0.811),and odds ratio of 0.727 (95% confidence interval, 0.656-0.805).Conclusions: In a propensity-matched cohort of adults with knee osteoarthritis and obesity, tirzepatide was associated with a lower crude cumulative incidence of TKA than semaglutide.These results warrant careful study using standardized follow-up intervals and procedure-specific outcome definitions.
Zitieren
APA
Al‐Ajlouni, Y., Al‐Shamari, A., Gopal, A. F., Coppinger, C., Palatulan, E., & Garvey, N. (2026). Adverse Event Patterns of Anterior Cruciate Ligament Fixation Devices: A Manufacturer and User Facility Device Experience (MAUDE) Database Analysis (2016–2025). PM&R, 18(S3). https://doi.org/10.1002/pmrj.81_70259
Vancouver
Al‐Ajlouni Y, Al‐Shamari A, Gopal AF, Coppinger C, Palatulan E, Garvey N. Adverse Event Patterns of Anterior Cruciate Ligament Fixation Devices: A Manufacturer and User Facility Device Experience (MAUDE) Database Analysis (2016–2025). PM&R. 2026;18(S3). doi:10.1002/pmrj.81_70259
BibTeX
@article{AlAjlouni2026,
author = {Al‐Ajlouni, Yazan and Al‐Shamari, Abdulrahman and Gopal, Ariana F. and Coppinger, Clay and Palatulan, Eugene and Garvey, Nicholas},
title = {Adverse Event Patterns of Anterior Cruciate Ligament Fixation Devices: A Manufacturer and User Facility Device Experience (MAUDE) Database Analysis (2016–2025)},
journal = {PM&R},
year = {2026},
volume = {18},
number = {S3},
doi = {10.1002/pmrj.81_70259}
}
EUVIMED